Chronic kidney disease and dialysis in Mexico

被引:0
|
作者
Paniagua, Ramon
Ramos, Alfonso
Fabian, Rosaura
Lagunas, Jesus
Amato, Dante
机构
[1] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo 21, Unidad Invest Med Enfermedades Nefrol, Col Doctores Mexico, DF, Mexico
[2] Hosp Gen Zona 1 Hermosillo, Hermosillo, Sonora, Mexico
[3] UMAE Hosp Gen Gaudencio Gonzalez Garza, Mexico City, DF, Mexico
[4] Inst Mexicano Seguro Social, Mexico City, DF, Mexico
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2007年 / 27卷 / 04期
关键词
chronic kidney disease; mexico;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The increasing rates in incidence and prevalence of chronic kidney disease (CKD) are important challenges for health systems around the world, and are even more significant for undeveloped countries. In Mexico the prevalence of CKD seems to be similar to that in highly developed nations, with diabetes as the leading cause of CKD; however, human and economic resources seem to be insufficient for treatment needs. This is reflected in the unacceptably high mortality rates and in noncompliance with established standards and guidelines. Several measures need to be taken to improve this picture, such as more efficient programs for the prevention of obesity, diabetes, and hypertension. Organizing a national registry of patients with CKD is now a pressing need, as is a continuous search for additional funding and budgets to increase the number of qualified nephrotogists and specialized nurses and to continue the much-needed research on CKD.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 50 条
  • [21] Vadadustat for Anemia in chronic Kidney Disease with or without Dialysis
    Wagner, Annkatrin
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 152 - +
  • [22] Gangrene of penis in a patient with chronic kidney disease on dialysis
    Alzaarir, Hussam
    Rizziki, Abdellah
    Miry, Achraf
    Benzirar, Adnane
    Bennani, Amal
    Mahi, Omar El
    INDIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 7 (04) : 438 - 440
  • [23] Hypertension in chronic kidney disease and dialysis: Pathophysiology and management
    Agarwal, R
    CARDIOLOGY CLINICS, 2005, 23 (03) : 237 - +
  • [24] Cancer Drug Dosing in Chronic Kidney Disease and Dialysis
    Shirali, Anushree C.
    Sprangers, Ben
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2022, 29 (02) : 208 - +
  • [25] Statins for Non-Dialysis Chronic Kidney Disease
    Hitzeman, Nathan
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (01) : 27 - 29
  • [26] The role of chronic peritoneal dialysis in the management of the patient with chronic kidney disease
    Finkelstein, Fredric O.
    Finkelstein, Susan H.
    Troidle, Laura K.
    PERITONEAL DIALYSIS: A CLINICAL UPDATE, 2006, 150 : 235 - 239
  • [27] Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis
    Levin, A
    SEMINARS IN DIALYSIS, 2003, 16 (02) : 101 - 105
  • [28] Dialysis Disequilibrium Syndrome in a Patient With Acute Kidney Injury on Chronic Kidney Disease
    Sanada, Hajime
    Yamaguchi, Kaori
    Miyake, Taito
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [29] Transition of Care in Children with Chronic Kidney Disease, Dialysis, and Transplantation
    Riar, Sandeep
    Srivastava, Tarak
    George, Roshan
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (12): : 1237 - 1244
  • [30] Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis
    Velenosi, Thomas J.
    Urquhart, Bradley L.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1131 - 1143